EA200600216A3 - Method of protection immune state in an organism suffering from diabetes mellitus - Google Patents
Method of protection immune state in an organism suffering from diabetes mellitusInfo
- Publication number
- EA200600216A3 EA200600216A3 EA200600216A EA200600216A EA200600216A3 EA 200600216 A3 EA200600216 A3 EA 200600216A3 EA 200600216 A EA200600216 A EA 200600216A EA 200600216 A EA200600216 A EA 200600216A EA 200600216 A3 EA200600216 A3 EA 200600216A3
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- diabetes mellitus
- immune state
- organism suffering
- protection immune
- protection
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Изобретение относится к медицине, в частности к эндокринологии и иммунологии, и касается коррекции патологического иммунного процесса при сахарном диабете типа II. Повышение эффективности способа и сокращение сроков лечения достигается тем, что в способе коррекции иммунного состояния организма, включающем введение антиидиотипических антител, согласно изобретению используют антиидиотипические антитела к α-фетопротеину.The invention relates to medicine, in particular to endocrinology and immunology, and concerns the correction of the pathological immune process in diabetes mellitus type II. Improving the efficiency of the method and reducing the time of treatment is achieved by the fact that the method of correction of the immune state of the body, including the introduction of antiidiotypic antibodies, according to the invention uses antiidiotypic antibodies to α-fetoprotein.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KZ20041770 | 2004-12-14 |
Publications (3)
Publication Number | Publication Date |
---|---|
EA200600216A2 EA200600216A2 (en) | 2006-08-25 |
EA200600216A3 true EA200600216A3 (en) | 2006-10-27 |
EA008925B1 EA008925B1 (en) | 2007-08-31 |
Family
ID=40848965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200600216A EA008925B1 (en) | 2004-12-14 | 2005-12-12 | Method of protection immune state in an organism suffering from diabetes mellitus |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA008925B1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6887096A (en) * | 1996-09-11 | 1998-04-02 | Patrick T. Prendergast | Immune direction therapy |
US6696545B1 (en) * | 1997-04-11 | 2004-02-24 | Sangstat Medical Corporation | Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
CN1281978A (en) * | 2000-07-13 | 2001-01-31 | 厦门大学 | Anti-alpha-fetoprotein antibody labelled by fluorescein and its preparation method |
RU2228198C1 (en) * | 2002-08-21 | 2004-05-10 | Полетаев Александр Борисович | Method for adjusting pathological autoimmune process in the cases of diabetes mellitus |
-
2005
- 2005-12-12 EA EA200600216A patent/EA008925B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EA008925B1 (en) | 2007-08-31 |
EA200600216A2 (en) | 2006-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200800812A1 (en) | Antibody Anti-CD3 Compositions | |
EA200970262A1 (en) | COMPOSITIONS AND METHODS RELATING TO ANTIBODIES TO GLUCAGON RECEPTORS | |
EA200801427A1 (en) | ANTIBODY MOLECULES WITH SPECIFIC ACTIVITY WITH RESPECT TO HUMAN INTERLEUKIN-6 (IL-6) | |
EA201070553A1 (en) | ANTIBODIES TO HEPCIDIN AND VARIANTS OF THEIR APPLICATION | |
EA200800763A1 (en) | THERAPEUTIC COMPOSITIONS CONTAINING HYALURONIC ACID AND THERAPEUTIC ANTIBODIES AND ALSO WAYS OF TREATMENT | |
GB2433936B (en) | Therapeutic peptides | |
WO2004047728A3 (en) | Compositions and methods for the treatment of immune related diseases | |
WO2005019258A3 (en) | Compositions and methods for the treatment of immune related diseases | |
EA200701092A1 (en) | Interleukin-21 antigen epitopes, associated antibodies and their use in medicine. | |
WO2003100033A3 (en) | ANTI-αvβ6 ANTIBODIES | |
SG170749A1 (en) | Anti-ilt7 antibody | |
EP2107071A3 (en) | Anti-EpCAM immunoglobulins | |
PL1648513T3 (en) | Use of adcc-optimized antibodies for treating patients answering weakly to antibody treatment. | |
TW200635946A (en) | Binding proteins specific for human matriptase | |
HK1108568A1 (en) | Method of preventive treatment of allergy by mucosal administration of an allergy vaccine | |
RU2008152769A (en) | HUMANIZED ANTIBODY AGAINST HUMAN OSTEOPONTIN | |
EA200801310A1 (en) | PHARMACEUTICAL PREPARATIONS AND THEIR APPLICATION IN THE TREATMENT OF SEXUAL DYSFUNCTION IN WOMEN | |
PE20050962A1 (en) | FULLY HUMAN ANTIBODIES VS HUMAN 4-1BB | |
WO2004024072A3 (en) | Novel compositions and methods for the treatment of immune related diseases | |
EA200501078A1 (en) | Phenoxyethers of Amino Acid | |
EA200600216A2 (en) | Method of protection immune state in an organism suffering from diabetes mellitus | |
EA200700425A1 (en) | GLYCOPROTEIN CELLULAR SURFACE | |
WO2007012671A3 (en) | Method for genetic immunization by electrotransfer against a toxin and antiserum obtainable by said method | |
WO2003097082A3 (en) | Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies | |
EA200600218A3 (en) | Method of correction an organism immune state in anemia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): KZ |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |